MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $436,000 | -13.1% | 16,300 | +7.8% | 0.02% | -14.3% |
| Q1 2019 | $502,000 | +42.6% | 15,120 | +22.9% | 0.02% | +31.2% |
| Q4 2018 | $352,000 | +153.2% | 12,300 | +310.0% | 0.02% | +220.0% |
| Q3 2018 | $139,000 | -10.9% | 3,000 | -28.5% | 0.01% | -28.6% |
| Q2 2018 | $156,000 | +75.3% | 4,193 | +39.8% | 0.01% | +75.0% |
| Q1 2018 | $89,000 | -14.4% | 3,000 | 0.0% | 0.00% | -42.9% |
| Q4 2017 | $104,000 | -4.6% | 3,000 | 0.0% | 0.01% | -12.5% |
| Q3 2017 | $109,000 | +41.6% | 3,000 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $77,000 | +35.1% | 3,000 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $57,000 | +14.0% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $50,000 | -95.3% | 3,000 | -94.1% | 0.01% | -94.5% |
| Q3 2016 | $1,054,000 | – | 50,934 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |